Development of an integrated risk stratification model for metastatic medulloblastoma (M2/3) using clinical, radiologic, and molecular variables
{{output}}
Background: Approximately 20% of medulloblastoma (MB) patients are diagnosed with metastatic disease and typically exhibit extremely poor clinical outcomes. This study aimed to investigate potential prognostic factors affecting t... ...
